Cargando…

Advanced nanomaterials for modulating Alzheimer's related amyloid aggregation

Alzheimer's disease (AD) is a common neurodegenerative disease that brings about enormous economic pressure to families and society. Inhibiting abnormal aggregation of Aβ and accelerating the dissociation of aggregates is treated as an effective method to prevent and treat AD. Recently, nanomat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Xu, Yan, Chaoren, Wang, Chao, Wang, Chaoli, Cao, Yue, Zhou, Yang, Guan, Ping, Hu, Xiaoling, Zhu, Wenlei, Ding, Shichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765474/ https://www.ncbi.nlm.nih.gov/pubmed/36605800 http://dx.doi.org/10.1039/d2na00625a

Ejemplares similares

Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid-β aggregation and inhibiting fungal infection
por: Yan, Chaoren, et al.
Publicado: (2021)

Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides
por: Huang, Yaliang, et al.
Publicado: (2021)

Bleomycin modulates amyloid aggregation in β-amyloid and hIAPP
por: Kumari, Anchala, et al.
Publicado: (2020)

Modulation of β-amyloid aggregation by graphene quantum dots
por: Liu, Changliang, et al.
Publicado: (2019)

Alzheimer's Therapeutic Strategy: Photoactive Platforms for Suppressing the Aggregation of Amyloid β Protein
por: Li, Chenglong, et al.
Publicado: (2020)

Morphological Determinants of Carbon Nanomaterial-Induced Amyloid Peptide Self-Assembly
por: Xing, Yanting, et al.
Publicado: (2020)

Amyloids and protein aggregation
por: Linse, Sara, et al.
Publicado: (2023)

Impact of porous nanomaterials on inhibiting protein aggregation behaviour
por: Bardhan, Munmun, et al.
Publicado: (2021)

Chelation-induced diradical formation as an approach to modulation of the amyloid-β aggregation pathway
por: Porter, Meghan R., et al.
Publicado: (2015)

Destabilization of amyloid fibrils on interaction with MoS(2)-based nanomaterials
por: Mudedla, Sathish Kumar, et al.
Publicado: (2019)

Structural Remodeling Mechanism of the Toxic Amyloid Fibrillary Mediated by Epigallocatechin-3-gallate
por: Zhang, Nan, et al.
Publicado: (2022)

Ameliorating amyloid aggregation through osmolytes as a probable therapeutic molecule against Alzheimer's disease and type 2 diabetes
por: Kumari, Anchala, et al.
Publicado: (2020)

Recent Advances of Magnetic Nanomaterials in Bone Tissue Repair
por: Fan, Daoyang, et al.
Publicado: (2020)

Decreasing amyloid toxicity through an increased rate of aggregation
por: Sonzini, Silvia, et al.
Publicado: (2017)

Recent advances in peptide-based nanomaterials for targeting hypoxia
por: Wang, Jun, et al.
Publicado: (2021)

Decoding Conformational Imprint of Convoluted Molecular Interactions Between Prenylflavonoids and Aggregated Amyloid-Beta42 Peptide Causing Alzheimer’s Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Heterometallic nanomaterials: activity modulation, sensing, imaging and therapy
por: Li, Shan-Shan, et al.
Publicado: (2022)

Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
por: Phan, Huong T. T., et al.
Publicado: (2019)

Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation
por: Melchor, Martínez-Herrera, et al.
Publicado: (2018)

Current understanding of metal-dependent amyloid-β aggregation and toxicity
por: Yi, Yelim, et al.
Publicado: (2022)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

Current advances in nanomaterials affecting morphology, structure, and function of erythrocytes
por: Tian, Yaxian, et al.
Publicado: (2021)

Responsive Plasmonic Nanomaterials for Advanced Cancer Diagnostics
por: Lu, Rong, et al.
Publicado: (2021)

Editorial: Recent Advances in Responsive Optical Nanomaterials
por: Li, Zhiwei, et al.
Publicado: (2021)

Editorial: Advanced Silica Nanomaterials for Drug Delivery
por: Liu, Xijian, et al.
Publicado: (2021)

Advanced hematite nanomaterials for newly emerging applications
por: Wan, Hao, et al.
Publicado: (2023)

Monitoring Alzheimer Amyloid Peptide Aggregation by EPR
por: Sepkhanova, I., et al.
Publicado: (2009)

Magnetoelectric dissociation of Alzheimer’s β-amyloid aggregates
por: Jang, Jinhyeong, et al.
Publicado: (2022)

Monitoring amyloid aggregation via a twisted intramolecular charge transfer (TICT)-based fluorescent sensor array
por: Wang, Chao, et al.
Publicado: (2023)

Regulation of divalent metal ions to the aggregation and membrane damage of human islet amyloid polypeptide oligomers
por: Wang, Yajie, et al.
Publicado: (2021)

Bifunctional fluorescent probes for detection of amyloid aggregates and reactive oxygen species
por: Needham, Lisa-Maria, et al.
Publicado: (2018)

Single molecule sensing of amyloid-β aggregation by confined glass nanopores
por: Yu, Ru-Jia, et al.
Publicado: (2019)

Turn-on fluorescent sensors for Cu-rich amyloid β peptide aggregates
por: Huang, Yiran, et al.
Publicado: (2022)

Xanthone-based solvatochromic fluorophores for quantifying micropolarity of protein aggregates
por: Wang, Lushun, et al.
Publicado: (2022)

β-Hairpin mimics containing a piperidine–pyrrolidine scaffold modulate the β-amyloid aggregation process preserving the monomer species
por: Pellegrino, S., et al.
Publicado: (2017)

The Role of Nanomaterials in Modulating the Structure and Function of Biomimetic Catalysts
por: Huang, Yanyan, et al.
Publicado: (2020)

Editorial: Advances in nano-scale systems with optics (nano-chemical, nanomaterial, and nano-biomedicine)
por: Zhang, Si-Wei, et al.
Publicado: (2022)

Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau
por: Guan, Pei-Pei, et al.
Publicado: (2021)

Photoactive chlorin e6 is a multifunctional modulator of amyloid-β aggregation and toxicity via specific interactions with its histidine residues
por: Leshem, Guy, et al.
Publicado: (2018)

The polyphenolic phytoalexin polydatin inhibits amyloid aggregation of recombinant human prion protein
por: Sirohi, Preeti Rana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ji0nfhtprkv9trbl7jv8frb9h1